Thomas Reilly
Equibles does not estimate personal net worth.
Get an email with a short summary when Tvardi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TVRD alertsAbout Thomas Reilly
Thomas Reilly is recorded as CFO at Tvardi Therapeutics, Inc. (TVRD) since October 1, 2020. The proxy statement of Tvardi Therapeutics, Inc. reports total compensation of $810,003 for Thomas Reilly in fiscal 2021, including a base salary of $412,000. Disclosed compensation is on record for 2 fiscal years. Tvardi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tvardi Therapeutics, Inc. includes Derek Chalmers (CEO), Imran Alibhai (CEO and Board Member), Imran Alibhai, Ph.D. (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2020-10-01–present
-
Start not stated–2022-06-15
Company network
Leadership on record at Tvardi Therapeutics, Inc.
- Derek Chalmers CEO
- Imran Alibhai CEO, Board Member
- Imran Alibhai, Ph.D. CEO, Board Member
- Sujal Shah Chairman, Board Member
- Dan Conn CFO
- Dan Conn, J.D., M.B.A CFO
- Dan Conn, J.D., M.B.A. CFO
- Mani Mohindru CFO
- Ryan Maynard CFO
- Scott M. Terrillion General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Tvardi Therapeutics, Inc. (TVRD) | Chief Financial Officer | $412,000 | $810,003 |
| 2020 | Tvardi Therapeutics, Inc. (TVRD) | Chief Financial Officer | $100,000 | $1,588,458 |
Recent activity
No call appearances or filed executive changes recorded yet.